Photo taken from Erman Akkus/X
May 19, 2024, 10:12
Erman Akkus: Is oncologic treatment of very advanced disease associated with improved survival?
Erman Akkus, Medical Oncology Fellow at Ankara University shared a post on X:
“Is oncologic treatment of very advanced disease associated with improved survival?
No differences in OS between patients treated at the highest and the lowest NQF 0210 quintiles
- NQF 0210 (patients receiving chemotherapy in the last 14 days of life).
- breast cancer, colorectal cancer, non–small cell lung cancer [NSCLC], pancreatic cancer, renal cell carcinoma, and urothelial cancer.
- 78 446 patients.
️Need of tools to identify when additional therapy is futile or necessary.”
Read further.
Source: Erman Akkus/X
.
advanced disease
Ankara University
Breast Cancer
cancer
chemotherapy
colorectal cancer
end-of-life care
end-of-life therapy
Erman Akkus
medical oncology
NQF 0210
NSCLC
OncoDaily
oncologic treatment
Oncology
oncology research
Pancreatic Cancer
patient outcomes
renal cell carcinoma
survival analysis
survival outcomes
treatment futility
urothelial cancer
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 12, 2024, 23:10
Nov 12, 2024, 23:07
Nov 12, 2024, 22:58
Nov 12, 2024, 22:56
Nov 12, 2024, 22:50
Nov 12, 2024, 22:46
Nov 12, 2024, 22:43